This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Law & Regulation Remove Medicine Remove Safety Related Topics
Key account management Food and Drug Administration Sales FDA Patients Consulting Transportation Electronics Government Pharmaceutical More Related Topics >
article thumbnail

New quality requirements for tobacco products

European Pharmaceutical Review

JUNE 8, 2023

9″ It will be interesting to see whether FDA tries to control carcinogenic TSNAs in tobacco products using an acceptable intake (AI) strategy, aligned with approaches applied to medicinal products for nitrosamines. He is currently a CMC consultant with an interest in impurities and safety‑based limits. 01 February 2023.

Food and Drug Administration 59
Food and Drug Administration FDA Manufacturing Law & Regulation 59
article thumbnail

How the Ukrainian clinical trial industry is overcoming disruption

Pharmaceutical Technology

SEPTEMBER 26, 2022

Research recommencing has been accelerated by ingenuity from Ukrainian policymakers and businesses in two key areas: law and logistics. Requirements on imports, packaging, storage and circulation of medical products and devices have been eased, while continuing to uphold product requirements for efficacy and patient safety.

Transportation 52
Transportation Law & Regulation Key account management Management 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024